Dixon Hubard Feinour & Brown Inc Stryker Corp Transaction History

Dixon Hubard Feinour & Brown Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$126.5 - $225.1 $6.26 Million - $11.1 Million	-49,513 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$197.98 - $220.53 $122,747 - $136,728	-620 Reduced 1.24%	49,513 $10.4 Million
Q3 2019 Nov 13, 2019	BUY	$205.4 - $221.82 $52,377 - $56,564	255 Added 0.51%	50,133 $10.8 Million
Q2 2019 Aug 14, 2019	BUY	$180.24 - $205.58 $345,339 - $393,891	1,916 Added 3.99%	49,878 $10.3 Million
Q1 2019 May 17, 2019	SELL	$152.46 - $198.0 $386,638 - $502,128	-2,536 Reduced 5.02%	47,962 $9.47 Million
Q4 2018 Feb 13, 2019	SELL	$145.0 - $178.65 $87,000 - $107,190	-600 Reduced 1.17%	50,498 $7.92 Million
Q3 2018 Nov 06, 2018	SELL	$163.25 - $177.68 $26,936 - $29,317	-165 Reduced 0.32%	51,098 $9.08 Million
Q2 2018 Jul 25, 2018	SELL	$155.17 - $179.78 $176,893 - $204,949	-1,140 Reduced 2.18%	51,263 $8.66 Million
Q1 2018 May 14, 2018	SELL	$148.01 - $168.91 $142,829 - $162,998	-965 Reduced 1.81%	52,403 $8.43 Million
Q4 2017 Feb 20, 2018	SELL	$143.51 - $159.74 $109,785 - $122,201	-765 Reduced 1.41%	53,368 $8.26 Million
Q3 2017 Nov 08, 2017	BUY	$138.36 - $147.87 $7.49 Million - $8 Million	54,133	54,133 $7.69 Million

2,226

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.